Abstract: An object of the present invention is to provide a sustained-release injectable preparation which is in a medication administration form that can provide the effect of 7-[4-(4-benzo[b]thiophen-4-yl-piperazin-1-yl)butoxy]-1H-quinolin-2-one for a prolonged period of time, the preparation releasing a therapeutically effective amount of 7-[4-(4-benzo[b]thiophen-4-yl-piperazin-1-yl)butoxy]-1H-quinolin-2-one for at least one week. The present invention provides an injectable preparation containing 7-[4-(4-benzo[b]thiophen-4-yl-piperazin-1-yl)butoxy]-1H-quinolin-2-one or a salt thereof as an active ingredient, which releases the active ingredient in such a manner that its blood concentration is maintained for at least one week.

Abstract: A metal collector for a pipeline disclosed herein includes: a first magnet arranged on an outer surface of a pipeline in a state where a N pole is directed toward an inner side of the pipeline and a S pole is directed toward an outer side; a second magnet arranged on another part of the outer surface of the pipeline in a state where a S pole is directed toward the inner side and a N pole is directed toward the outer side; a magnetic circuit forming member that is a ferromagnetic material connected to the S pole of the first magnet and the N pole of the second magnet. The metal collector can remove the metal foreign substance from the fluid inside the pipeline.

Abstract: The present invention provides: an electrode plate for secondary batteries, which has high reliability; and a secondary battery which uses this electrode plate. A negative electrode plate for secondary batteries, which comprises: a negative electrode core body that is formed of a metal; and negative electrode active material layers that are formed on both surfaces of the negative electrode core body. This negative electrode plate has a first edge and a negative electrode tab which protrudes from the first edge; and a coating film containing silicon is formed on the end face of the negative electrode core body at the first edge. A secondary battery according to the present invention is provided with a positive electrode plate and the negative electrode plate.

Abstract: Provided are: a highly reliable secondary battery electrode plate; and a secondary battery using same. The electrode plate is a positive electrode plate for a secondary battery, the positive electrode plate having a metallic positive electrode core body and a positive electrode active material layer formed on both surfaces of the positive electrode core body, wherein the positive electrode plate has a first edge and a positive electrode tab protruding from the first edge, and a fluorine-containing coating is formed on the end surface of the positive electrode core body at the first edge of the positive electrode plate. The secondary battery has the positive electrode plate and a negative electrode plate.

Abstract: In an uncoated region (16a) of a current collector (16) of a lithium-ion secondary battery (10), first codes (18) are formed along a longitudinal axis thereof. A first inspection device (105) and a second inspection device (107) record inspection information in a recording device (210) while identifying the position of an active material layer (17) using the first codes (18). It is possible to retrospectively acquire the inspection information on the active material layer (17) corresponding to the position of each of the first codes (18) in the longitudinal axis of the current collector (16), making it possible to predict or retrospectively identify individual differences between electrode materials used in cells.

Abstract: According to one embodiment, a liquid processing device includes a liquid flow path connected to a liquid ejecting head. A control unit is also provided. The control unit is configured to begin an operation to cause liquid to flow in the liquid flow path to the liquid ejecting head, receive a pressure value for liquid in the liquid flow path, and stop the operation when the pressure value is outside a normal range. Such a device can avoid damage resulting from malfunctions and the like.

Abstract: According to one embodiment, a liquid ejection head includes an actuator with pressure chambers, a first common chamber on a first side of the pressure chambers, a second common chamber on a second side of the pressure chambers, and a manifold providing a first liquid flow path above the first common chamber, a first cooling flow path above the second common chamber, and a second liquid flow path above the first cooling flow path. The second liquid flow path is connected to the first liquid flow path by a confluence portion at a confluence position between a first end of the first liquid flow path and a midpoint of the first liquid flow path.

Abstract: A film forming method selectively performs film formation. The film forming method includes a cooling operation and a film forming operation. The cooling operation includes cooling a substrate to a temperature at which molecules of a c-C4F8 gas and a SF6 gas condense on a surface of the substrate, the substrate having a metal film and a first insulating film exposed on the surface and being supported inside a chamber. The film forming operation includes forming a carbon-containing film on the metal film by supplying a processing gas including the c-C4F8 gas and the SF6 gas into the chamber while exciting the surface of the substrate.

Abstract: A method of manufacturing a battery includes the steps of: weighing a plurality of electrode materials to respective predetermined weights and placing the plurality of electrode materials into a container; placing the plurality of electrode materials having been placed in the container into a feeder machine; feeding the plurality of electrode materials from the feeder machine to a twin-screw kneader; and kneading the plurality of electrode materials with the twin-screw kneader.

Abstract: An object of the present invention is to provide a sustained-release injectable preparation which is in a medication administration form that can provide the effect of 7-[4-(4-benzo[b]thiophen-4-yl-piperazin-1-yl)butoxy]-1H-quinolin-2-one for a prolonged period of time, the preparation releasing a therapeutically effective amount of 7-[4-(4-benzo[b]thiophen-4-yl-piperazin-1-yl)butoxy]-1H-quinolin-2-one for at least one week. The present invention provides an injectable preparation containing 7-[4-(4-benzo[b]thiophen-4-yl-piperazin-1-yl)butoxy]-1H-quinolin-2-one or a salt thereof as an active ingredient, which releases the active ingredient in such a manner that its blood concentration is maintained for at least one week.

Abstract: The present technology relates to an information processing terminal, an information processing method, and a program that make it possible to easily operate multiple devices configuring a group in a sense of feeling similar to that when a device of a single piece is operated. The information processing terminal according to one aspect of the present technology causes a selection screen for an operation target to be displayed, the selection screen including information concerning a group including multiple devices selected from among devices registered in a server and information concerning the devices of a single piece that do not belong to the group, and requests the server to collectively control the devices configuring the group according to a selected operation target and control the devices of a single piece. The present technology can be applied to a system in which devices connected to a network are controlled.

Abstract: A secondary battery with a positive electrode plate having a metallic positive electrode core body and positive electrode active material layers formed on both surfaces of the positive electrode core body. The positive electrode core body has an active material layer-free region in which the positive electrode active material layers are not formed on the surface of the positive electrode core body, wherein a first protrusion protruding in the thickness direction of the positive electrode core body from one surface of the positive electrode core body is formed at the end of the active material layer-free region, positive electrode protection layers are formed in a portion adjacent to the positive electrode active material layers on one surface of the positive electrode core body in the active material layer-free region, and the protrusion height T1 of the first protrusion is less than the thickness T2 of the positive electrode protection layer.

Abstract: To provide a rehabilitation assistance device, a rehabilitation assistance method, and a non-transient storage medium storing a rehabilitation assistance program that support continuous rehabilitation by enabling the generation of a rehabilitation plan that can increase the motivation to continue rehabilitation. When a patient selects one set from an activity event information DB that stores a plurality of sets that associate information of a predetermined activity event with information of an exercise amount for each of a plurality of body parts when the activity event is performed, the patient can check on the screen displayed on the display unit to what extent the exercise amount contained in one's rehabilitation plan information is achieved by the activity event of the selected set.

Abstract: A robot control system sets a plurality of limit parameter sets for limiting a motion of the robot based on an input by a user, in which each of the plurality of limit parameter sets corresponds to a scene in which the robot moves, and includes a main parameter set and one of a plurality of sub-parameter sets, the main parameter set including at least one limit parameter, each of the plurality of sub-parameter sets including at least one limit parameter, and the plurality of sub-parameter sets being dependent on the main parameter set, applies one of the set plurality of limit parameter sets to the robot, controls a motion of the robot according to applied one of the plurality of limit parameter sets, and switches the plurality of limit parameter sets at least by switching one of the plurality of sub-parameter sets.

Abstract: One or more of HLA gene primers selected from the group consisting of the following (1) to (3): (1) one or more HLA-G gene primers which are (1a) a first primer including the nucleotide sequence of SEQ ID NO. 1 and/or (1b) a second primer including the nucleotide sequence of SEQ ID NO. 3, (2) one or more HLA-E gene primers which are (2a) a first primer including the nucleotide sequence of SEQ ID NO. 5 and/or (2b) a second primer including the nucleotide sequence of SEQ ID NO. 7, and (3) one or more HLA-F gene primers which are (3a) a first primer including the nucleotide sequence of SEQ ID NO. 9 and/or (3b) a second primer including the nucleotide sequence of SEQ ID NO. 11.

Abstract: A rail-guided cart system includes a traveling rail and a traveling cart to travel along the traveling rail. The rail-guided cart system includes a measurement sensor and a diagnosis processor. The measurement sensor is fixed with respect to the traveling rail to measure vibration or sound. The diagnosis processor diagnoses a condition of the traveling cart that passed through a measurement point on the traveling rail corresponding to a location of the measurement sensor. based on measurement data measured by the measurement sensor.

Abstract: The brush device comprises: a plurality of discharge brushes formed by bundling fibrous wire electrodes; a strip-shaped support board including a first plate-shaped member and a second plate-shaped member which hold the discharge brushes from both sides; and a joining means for joining the first plate-shaped member and the second plate-shaped member. The discharge brushes are disposed at intervals in a longitudinal direction of the support board with their tip end portions protruding from the support board along a width direction of the support board, and the joining means is disposed adjacent to each of the discharge brushes.

Abstract: An object of the present invention is to provide a compound that can be used as a more superior therapeutic agent for central nervous system diseases.

Abstract: A secondary-battery electrode manufacturing method that allows a secondary-battery electrode including a neat linear cut portion to be stably manufactured at a high speed is provided. A method of manufacturing a secondary-battery electrode (10), which is an example of an embodiment, comprises a first step of forming an active material layer (22) on at least one surface of a long core body (21). The method of manufacturing the secondary-battery electrode (10), which is an example of the embodiment also comprises a second step of cutting an electrode precursor (20) into a predetermined shape by using a continuous wave laser, the electrode precursor (20) being the long core body (21) having the active material layer (22) formed thereon.

Abstract: An apparatus and method for performing authentication using biometric authentication processing at a portable terminal connected to a multifunction peripheral (MFP) is provided. A web application accesses the portable terminal via a web browser of the MFP and the MFP transmits a request for information about service to the portable terminal. In a case where information corresponding to the web application is included in the information about service received from the portable terminal responsive to the request, the MFP transmits an authentication request to the portable terminal according to a request from the web application, and transmits, to the web application, an authentication result received from the portable terminal responsive to the authentication request.